Johnson & Johnson (JNJ)

$ 230.75
   
  • Change Today:
    $3.50
  • 52 Week High: $231.19
  • 52 Week Low: $146.36
  • Currency: US Dollars
  • Shares Issued: 2,406.92m
  • Volume: 8,186,357
  • Market Cap: $555,397m
  • RiskGrade: 87
  • Beta: 0.00

Latest ShareCast News

Johnson & Johnson expects further growth in 2026 as Q4 earnings jump

By Benjamin Chiou

Date: Wednesday 21 Jan 2026

(Sharecast News) - American healthcare and medical device giant Johnson & Johnson matched analysts' estimates with its fourth-quarter results, as earnings jumped on the back of improved sales of cancer and autoimmune drugs.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Johnson and Johnson Market Data

Currency US Dollars
Share Price $ 230.75
Change Today $ 3.50
% Change 1.54 %
52 Week High $231.19
52 Week Low $146.36
Volume 8,186,357
Shares Issued 2,406.92m
Market Cap $555,397m
Beta 0.00
RiskGrade 87

What The Brokers Say

Strong Buy 6
Buy 8
Neutral 12
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 02-Feb-2026

Time Volume / Share Price
15:59 600 @ $230.75
15:59 124 @ $230.81
15:59 100 @ $230.82
15:59 100 @ $230.83
15:59 100 @ $230.84

Top of Page